MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹3.66 Cr |
Mar2024 | ₹11 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3.66 Cr | -65.52 | |
Mar2024 | ₹11 Cr | -30.98 | |
Mar2023 | ₹15 Cr | 11.78 | |
Mar2022 | ₹14 Cr | 89.48 | |
Mar2021 | ₹7.26 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,897.0 Cr | -1.1% | -3.8% | -36.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.1% |
-3.8% |
-36.3% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses